Source:http://linkedlifedata.com/resource/pubmed/id/20699085
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0014834,
umls-concept:C0017262,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0205360,
umls-concept:C1439287,
umls-concept:C1514562,
umls-concept:C1880022,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221,
umls-concept:C1998793,
umls-concept:C2698650,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-9-29
|
pubmed:abstractText |
Aurora B kinase plays a critical role in regulating mitotic progression, and its dysregulation has been linked to tumorigenesis. The structure of the kinase domain of human Aurora B and the complementary information of binding thermodynamics of known Aurora inhibitors is lacking. Towards that effort, we sought to identify a human Aurora B construct that would be amenable for large-scale protein production for biophysical and structural studies. Although the designed AurB(69-333) construct expressed at high levels in Escherichia coli, the purified protein was largely unstable and prone to aggregation. We employed thermal-shift assay for high-throughput screening of 192 conditions to identify optimal pH and salt conditions that increased the stability and minimized aggregation of AurB(69-333). Direct ligand binding analyses using temperature-dependent circular dichroism (TdCD) and TR-FRET-based Lanthascreen™ binding assay showed that the purified protein was folded and functional. The affinity rank-order obtained using TdCD and Lanthascreen™ binding assay correlated with enzymatic IC50 values measured using full-length Aurora B protein for all the inhibitors tested except for AZD1152. The direct binding results support the hypothesis that the purified human AurB(69-333) fragment is a good surrogate for its full-length counterpart for biophysical and structural analyses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1096-0384
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
503
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-201
|
pubmed:dateRevised |
2011-7-11
|
pubmed:meshHeading |
pubmed-meshheading:20699085-Amino Acid Sequence,
pubmed-meshheading:20699085-Circular Dichroism,
pubmed-meshheading:20699085-Cloning, Molecular,
pubmed-meshheading:20699085-Enzyme Stability,
pubmed-meshheading:20699085-Escherichia coli,
pubmed-meshheading:20699085-Fluorescence Resonance Energy Transfer,
pubmed-meshheading:20699085-Humans,
pubmed-meshheading:20699085-Inhibitory Concentration 50,
pubmed-meshheading:20699085-Mass Spectrometry,
pubmed-meshheading:20699085-Molecular Sequence Data,
pubmed-meshheading:20699085-Molecular Weight,
pubmed-meshheading:20699085-Protein Folding,
pubmed-meshheading:20699085-Protein Structure, Tertiary,
pubmed-meshheading:20699085-Protein-Serine-Threonine Kinases,
pubmed-meshheading:20699085-Recombinant Fusion Proteins,
pubmed-meshheading:20699085-Sequence Homology, Amino Acid,
pubmed-meshheading:20699085-Thermodynamics
|
pubmed:year |
2010
|
pubmed:articleTitle |
Expression, purification, stability optimization and characterization of human Aurora B kinase domain from E. coli.
|
pubmed:affiliation |
Protein Science Department, Cambridge, MA 02141, USA. payal.sheth@spcorp.com
|
pubmed:publicationType |
Journal Article,
Comparative Study
|